Labour market · 17/03/1995Updated: 10/18/2026 · 1 min read

Genlyte Group Dismisses Reconsideration of Lightolier Model Shop Dismissal

Summary

The Genlyte Group has denied a request for reconsideration of its decision to dismiss the Lightolier Model Shop in Secaucus, NJ.

Original source language: Federal Register — Department of LaborOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Labour market · 10/23/2026

Georgiamune and Menarini Group sign exclusive global licensing and collaboration agreement for GIM-621

- Georgiamune and Menarini Group sign an exclusive global licensing and collaboration agreement for GIM-621, a pioneering oral immuno-oncological agent in its class GIM621 is a small molecule ad...

Read summary →

Labour market · 10/22/2026

Georgiamune and the Menarini Group conclude an exclusive global licensing and collaboration agreement on GIM-621, an innovative oral immuno-oncological agent

GIM-621 is an innovative, preclinical, small molecule oral immunotherapy that has potential for application in the treatment of several solid tumours.

Read summary →

Labour market · 10/22/2026

Tairex launched a multi-agent AI system to transform the collaboration clinique and help in decision making.

PÉKIN, 22 October 2026 — On 21 October, Tairex, a health technology society based on AI incubated by the Institute for AI Industry Research (AIR) of Tsinghua University, unveiled an ecosystem...

Read summary →

Labour market · 10/22/2026

Georgiamune and Menarini Group enter into an exclusive global license and collaboration agreement for GIM-621, a first-in-class oral immuno-oncology agent

GIM-621 is a preclinical stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors.

Read summary →

Labour market · 10/22/2026

Corra Group offers electronic I-9 services as the Employment Verification Evolves

As the verification of employment eligibility evolves, Corra Group offers electronic I-9 tools designed to help employers manage forms, deadlines and E-Verify workflows. EL SEGUNDO, Calif., Oct. 22, 2026 — For...

Read summary →

Labour market · 10/22/2026

Tairex launches multi-agent AI system to transform clinical collaboration and decision support

BEIJING, Oct. 22, 2026 — On October 21, Tairex, an AI healthcare technology company incubated by the Institute for AI Industry Research (AIR) at Tsinghua University, unveiled the Multidisciplinary Human- ...

Read summary →